Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red cell alloimmunization in multitransfused HLA-typed patients.

S G Brantley1, G Ramsey

  • 1Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.

Transfusion
|September 1, 1988
PubMed
Summary

This study found that red blood cell (RBC) alloantibodies are common in multiply transfused patients. HLA type was not associated with RBC alloantibody formation, but increased HLA alloimmunization was observed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood component transfusions in mass casualty events.

Vox sanguinis·2017
Same author

Morphometry and abnormalities of the feet of Kaimanawa feral horses in New Zealand.

Australian veterinary journal·2010
Same author

Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry.

Infection·2009
Same author

Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.

Vox sanguinis·2007
Same author

CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit.

Bone marrow transplantation·2001
Same author

A normal aPTT does not guarantee adequate coagulation factor levels.

Anesthesiology·2001

Area of Science:

  • Immunology
  • Transfusion Medicine
  • Genetics

Background:

  • Multiply transfused patients, including those undergoing transplantation, are at risk for developing red blood cell (RBC) alloantibodies.
  • Understanding the factors influencing RBC alloantibody formation is crucial for transfusion safety and patient outcomes.

Purpose of the Study:

  • To investigate the incidence of clinically significant RBC alloantibodies in multiply transfused patients.
  • To determine the association between Human Leukocyte Antigen (HLA) phenotype and RBC alloantibody formation.
  • To explore the relationship between HLA alloimmunization and RBC alloantibody presence.

Main Methods:

  • Retrospective analysis of 958 patients who received kidney or liver transplants or plateletpheresis.
  • HLA typing and screening for RBC alloantibodies, including Rh and Kell antibodies.

Related Experiment Videos

  • Statistical analysis to assess associations between HLA phenotype, alloimmunization, and RBC alloantibody formation.

    • Main Results:

    • RBC alloantibodies were detected in 9.5% of patients, with Rh and Kell antibodies being most prevalent.
    • No significant association was found between specific HLA-A, HLA-B, or HLA-DR phenotypes and RBC alloantibody presence.
    • Renal transplant recipients with RBC alloantibodies showed higher levels of HLA alloimmunization.

    Conclusions:

    • RBC alloantibody formation appears independent of HLA type in multiply transfused patients.
    • Increased HLA alloimmunization may be associated with a heightened immune response to RBC alloantigens.
    • These findings have implications for transfusion strategies and patient management.